Wells Fargo & Company Alx Oncology Holdings Inc Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
2 transactions
Others Institutions Holding ALXO
# of Institutions
122Shares Held
40.7MCall Options Held
518KPut Options Held
142K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$19.3 Million33.06% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.22MShares$8.4 Million3.76% of portfolio
-
Redmile Group, LLC San Francisco, CA4.04MShares$8.03 Million1.59% of portfolio
-
Vestal Point Capital, LP New York, NY3.6MShares$7.16 Million1.62% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$5.35 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $81.1M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...